Human breast cancers are classified into three subgroups, namely estrogen or progesterone receptor-positive (ER+ or PR+); Her2/neu-positive (HER2/neu+); and triple-negative breast cancer (TNBC) without ER, PR, and Her2/neu expression [1,2]. This evidence concerns the gene ERBB2 and breast cancer.